Axsome Therapeutics, Inc. AXSM

Set alert

Price alert · AXSM

All alert types
136.01 USD -8.42 -5.83%

At close · Nov 2

137.95 +1.94 +1.43%

After hours · Nov 2, 4:15 PM ET

Bid
135.81 × 2
Ask
136.01 × 2
123.00 Day range 138.03
123.00 52-week range 260.19
YTD
-25.53%
1 year
+0.76%
Open
137.15
Prev close
144.43
Mkt cap
7.12B
Vol
2.72M
Avg vol
783.05K
EPS
-3.74
P/E
0.00
Div yield
0.00%
More statistics
Low
123.00
High
138.03
Forward P/E
32.37
Beta
0.83
Short ratio
3.67
Inst. own
74.49%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2026
50-d avg
184.76
200-d avg
199.33
1y target
277.86

5D chart

Chart tools
Interval

Events in this range
  • Nov 2, 2026Earnings: —; estimate -0.63425; surprise —%
Signals (122)
NameTimeAgo
RSI: OverboughtNov 2, 3:40 PM7 hours ago
RSI: OverboughtNov 2, 3:05 PM8 hours ago
SMA: BullishNov 2, 2:30 PM8 hours ago
MACD: Buy SignalNov 2, 2:30 PM8 hours ago
SMA: BullishNov 2, 2:05 PM9 hours ago
SMA: BearishNov 2, 1:30 PM9 hours ago
SMA: BearishNov 2, 1:30 PM9 hours ago
MACD: Sell SignalNov 2, 1:30 PM9 hours ago
SMA: BullishNov 2, 1:15 PM10 hours ago
MACD: Buy SignalNov 2, 1:15 PM10 hours ago
MACD: Sell SignalNov 2, 1:10 PM10 hours ago
SMA: BearishNov 2, 12:50 PM10 hours ago
SMA: BullishNov 2, 11:45 AM11 hours ago
SMA: BullishNov 2, 11:15 AM12 hours ago
MACD: Buy SignalNov 2, 11:05 AM12 hours ago
MACD: Sell SignalNov 2, 10:55 AM12 hours ago
MACD: Buy SignalNov 2, 10:50 AM12 hours ago
SMA: BearishNov 2, 9:30 AM13 hours ago
SMA: BearishNov 2, 9:30 AM13 hours ago
MACD: Sell SignalNov 2, 9:30 AM13 hours ago

Newest 20 of 122.

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $530.00KUnited States → Revenue: $628.62MExpenses → Selling, General & Admin: $570.60MExpenses → Research & Development: $183.28MExpenses → Other Operating Expenses: $6.38MExpenses → Interest Expense: $6.56MExpenses → Other Expenses: $7.91MGross Profit → Expenses: $591.02MRevenue → Gross Profit: $591.02MRevenue → Cost of Revenue: $47.48MNon-US → Revenue: $5.18MNet Loss → Expenses: $183.17MIncome Tax Benefit$530.00KGross Profit$591.02MNet Loss$183.17MCost of Revenue$47.48MExpenses$774.72MSelling, General & Admin$570.60MResearch & Development$183.28MOther Operating Expenses$6.38MInterest Expense$6.56MOther Expenses$7.91MRevenue$638.50MUnited States$628.62MNon-US$5.18M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AXSM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
638.50M385.69M270.60M50.04M0
591.02M352.39M244.53M44.84M0
-166.76M-280.56M-231.82M-179.80M-124.71M
-183.17M-287.22M-239.24M-187.13M-130.40M
-3.68-5.99-5.27-4.60-3.47
AXSM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
322.93M315.35M386.19M200.84M86.47M
689.80M568.50M588.24M331.48M87.79M
601.51M511.48M397.26M221.92M72.15M
215.57M191.53M186.37M94.68M49.71M
88.30M57.02M190.98M109.56M15.63M
AXSM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-93.41M-128.41M-145.08M-116.51M-108.23M
-480.00K-270.00K-582.00K-53.70M-308.00K
101.47M57.84M331.01M284.58M11.13M
-480.00K-270.00K-582.00K-702.00K-308.00K
7.58M-70.84M185.35M114.37M-97.40M